Purchases and Sales Made in Q3 2023 in Myriad Genetics Inc (MYGN)
This table provides information about the institutional ownership of Myriad Genetics Inc (MYGN) during Q3 2023. The information is specifically focused on institutions that hold shares of MYRIAD GENETICS INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 06, 2023
Q3 2023
|
Amh Equity LTD
|
SELL
|
- |
-62.7K- 57.01% |
$1M - $1.46M
|
47.3K
$723K
|
|
Nov 09, 2023
Q3 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-81.9K- 3.06% |
$1.31M - $1.9M
|
2.59M
$39.7M
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-92K- 14.22% |
$1.47M - $2.14M
|
555K
$8.49M
|
|
Nov 01, 2023
Q3 2023
|
Bank Of Montreal
Toronto, A6 |
SELL
|
- |
-183K- 93.83% |
$2.93M - $4.25M
|
12.1K
$184K
|
|
Nov 09, 2023
Q3 2023
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-344K- 95.03% |
$5.5M - $7.98M
|
18K
$275K
|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-478K- 3.39% |
$7.64M - $11.1M
|
13.6M
$208M
|
|
Nov 14, 2023
Q3 2023
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-1.16M- 79.9% |
$18.5M - $26.8M
|
291K
$4.45M
|